Esoterix Clinical Trials Services, Inc.

Announcements

ECTS adds Tandem Laboratories to its capabilites network. Read more »

Tandem Labs

Esoterix Clinical Trials Services (ECTS) is pleased to introduce its new dedicated central laboratory in Cranford, NJ.  Read more »

ECTS / LabCorp launches initiative for comprehensive Companion Diagnostics services for the Pharmaceutical industry to identify, develop and commercialize biomarker assays to help identify patients suitable for specific drugs. Dr. David Johnston, Vice President and Chief Scientific Officer ECTS, appointed Director of Companion Diagnostics.

ECTS / LabCorp collaborates with ARCA Discovery to develop and commercialize an FDA approved pharmacogenetic test for the beta blocker Bucindolol.

ECTS / LabCorp collaborates with Glaxo Smith-Kline to launch a Website for HLA-B*5701 test orders in Europe.

The American Society of Clinical Oncology (ASCO) and College of American Pathologists (CAP) recently released Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 (HER-2) Testing in Breast Cancer, which were published in the Journal of Clinical Oncology and the Archives of Pathology and Laboratory Medicine. Read more »

ECTS invited to speak at the IIR Partnerships with Central Labs annual meeting January 22-25.
Speaker: David Johnston, Ph.D., Vice President and Chief Scientific Officer
Scientific Affairs and Laboratory Operations
Case Study: "A Novel Approach to Commercializing a Pharmacogenetic Companion Diagnostic to Predict Response to the beta-blocker Bucindolol"
Panelist: "Operational Future of Biomarker Development"

ECTS launches clinical trials services in India through new affiliate laboratory.

ECTS invited to present at Molecular Medicine Tri-Conference, March 26-28.

ECTS invited to present at the Annual DIA Conference, June 22-26.

ECTS invited to speak at Market Opportunities and Technology Trends in Molecular Diagnostics, June 4-5.

ECTS invited to speak at Clinical Trials in Cancer Conference, June 25-26.
Speaker: Dirk Vn Bockstaele, Ph.D., Director Flow Cytometry Laboratory
Title: "Flow Cytometry & (Single) Cell Analysis in Drug Discovery and Clinical Trials"

ECTS invited to speak at Clinical Biomarkers Forum, September 13-14.
Speaker: Dirk Vn Bockstaele, Ph.D., Director Flow Cytometry Laboratory
Title: "Flow Cytometry & (Single) Cell Analysis in Drug Discovery and Clinical Trials"

ECTS invited to speak at IFCC/Beckman Coulter Flow Cytometry Course, September 28-30
Speaker: Dirk Vn Bockstaele, Ph.D., Director Flow Cytometry Laboratory
Title: "Multiparameter strategies in rare event analysis"

ECTS invited to speak at BVAC/ABCA (Belgian Cytometry Society) Annual Symposium, October 26, 2007.
Speaker: Dirk Vn Bockstaele, Ph.D., Director Flow Cytometry Laboratory
Title: "Multiparameter strategies in rare event analysis"